May 7, 2023
Katie Shen
Share
https://pubmed.ncbi.nlm.nih.gov/36515952/
Should HBV genotype be considered in determining who to surveil for HCC?
March 21, 2022
Can seladelpar serve as second-line treatment for PBC patients with inadequate UDCA therapy?
October 27, 2025
HepMadness
October 15, 2025